Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Illumina, Inc. - Common Stock
(NQ:
ILMN
)
201.27
-3.73 (-1.82%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Illumina, Inc. - Common Stock
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
39
40
Next >
A Look Into Illumina's Debt
↗
March 06, 2023
Via
Benzinga
How Is The Market Feeling About Illumina?
↗
March 06, 2023
Via
Benzinga
Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States
March 02, 2023
Strategic partnership offers a unique combination of diagnostic development and commercialization capabilities to the pharmaceutical industry
From
Myriad Genetics, Inc.
Via
GlobeNewswire
The Next Generation Of Cancer Vaccines Are Coming; What That Means For Moderna And Other Biotech Stocks
↗
February 24, 2023
Startling cancer vaccine results from Moderna may point to the next big thing in biotech.
Via
Investor's Business Daily
DNA-Reading Giant Illumina Topples On Wide Profit Miss
↗
February 07, 2023
Sales narrowly topped expectations, however.
Via
Investor's Business Daily
If You Invested $100 In This Stock 10 Years Ago, You Would Have $400 Today
↗
February 07, 2023
Via
Benzinga
Earnings Preview For Illumina
↗
February 06, 2023
Via
Benzinga
7 Analysts Have This to Say About Illumina
↗
January 25, 2023
Via
Benzinga
Home Healthcare Equipment Market Trends, Volume, Growth Strategies Forecast Report 2023
February 16, 2023
Some of the major players profiled in the Home Healthcare Equipment Market report are Abbott Laboratories (US), F. Hoffman-La Roche (Switzerland), QIAGEN (Germany), Thermo Fisher Scientific (US),...
Via
SBWire
Topics
Economy
Cri-Du-Chat Syndrome Market Demand Trends Size Overview Analysis 2022-2029
February 14, 2023
Global Cri-du-chat Syndrome Market to Witness Huge Growth by Key Players: Centogene AG, Eurofins Scientific, Laboratory Corporation of America Holdings, Quest Diagnostics, PerkinElmer Inc., Natera,...
Via
SBWire
7 Stocks to Buy and Hold for the Next 20 Years
↗
February 12, 2023
When choosing stocks to buy and hold for the next 20 years, pick companies with strong comparative advantages in durable sectors.
Via
InvestorPlace
Cramer Likens This Stock To 'A Fine Merlot': It's Down 1% In 2023, So 'I Would Buy All You Can Right Here'
↗
February 08, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Parker-Hannifin Corp (NYSE: PH) is "just the kind of industrial I’ve been recommending."
Via
Benzinga
Illumina's Woes Mount As Guidance Lags And Grail Controversy Continues
↗
January 10, 2023
Illumina projected far lighter-than-expected profit guidance for 2023.
Via
Investor's Business Daily
Is Illumina Cheap or Expensive?
↗
December 14, 2022
It depends on which numbers you focus on.
Via
The Motley Fool
What 7 Analyst Ratings Have To Say About Illumina
↗
December 07, 2022
Via
Benzinga
New Survey Data Shows Innovation Teams at Large Companies Are Focusing More on Near-Term Initiatives, but Internal Politics and Culture Remain Top Challenges
February 07, 2023
InnoLead has released a 2023 update to its popular Benchmarking Innovation Impact research with KPMG LLP.
Via
Newswire.com
US Stocks Pause Ahead Of Powell's Speech: Analyst Warns Of Retest Of October Lows As Market, Economic Data Conspire Against Monetary Policy
↗
February 07, 2023
Stocks look set for another nervous session on Tuesday as traders look ahead to comments from Fed Chair Jerome Powell and another batch of earnings reports. Cues From Monday’s Trading:
Via
Benzinga
Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover
↗
February 06, 2023
Danaher is reportedly looking to add to its wheelhouse to compete with Thermo.
Via
Investor's Business Daily
Healthcare Sector Is Lagging As We Enter 2022 Earnings Season
↗
January 23, 2023
The healthcare sector is perceived as defensive but in 2023 there is more investor appetite for risk based on the QQQ comeback and the XBI strength.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For January 25, 2023
↗
January 25, 2023
Via
Benzinga
Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review
↗
January 13, 2023
Sharp Tesla price cuts and some notable earnings were in focus.
Via
Investor's Business Daily
Universal Sequencing Technology Corporation (UST) partners with TATAA Biocenter to offer Long Read Sequencing Services with TELL-Seq Linked-Read Tech
January 10, 2023
CARLSBAD, Calif. - Jan. 10, 2023 - PRLog -- Universal Sequencing Technology Corporation (UST) announces today, January 10th, 2022, that it has partnered with TATAA Biocenter, one of our key...
Via
PRLog
Topics
Intellectual Property
Illumina Shares Tank After Annual Guidance Fall Short Of Expectations
↗
January 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
January 10, 2023
Via
Benzinga
US Stocks Show Tentativeness On Tuesday As Traders Wait On Word From Fed Chair Jerome Powell
↗
January 10, 2023
U.S. stocks look set to start Tuesday’s session on a nervous note as traders may prefer to wait and watch the inflation data before making their next moves.
Via
Benzinga
QIAGEN Acquires Verogen Strengthening Its Position In Human ID / Forensics
↗
January 09, 2023
Via
Benzinga
What Does Illumina's Debt Look Like?
↗
January 04, 2023
Shares of Illumina Inc. (NASDAQ:ILMN) moved higher by 1.43% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
↗
January 05, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
December 12, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
↗
December 12, 2022
Via
Benzinga
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
39
40
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
